Group 1 - Kingsoft Software (03888) saw a nearly 5% drop in stock price, with Q1 revenue increasing by 9% year-on-year to 2.338 billion yuan, but net profit attributable to the parent company slightly decreased by 0.24% to 284 million yuan. Office software and services revenue grew by 6% year-on-year but fell by 13% quarter-on-quarter, while online gaming and other revenue increased by 14% year-on-year but decreased by 20% quarter-on-quarter [1] - Li Auto-W (02015) rose over 7%, reporting a 1.1% year-on-year revenue increase and a 9.4% rise in net profit for Q1. The company expects Q2 delivery volume to increase by 13.3%-17.9% year-on-year, with revenue projected to grow by 2.5%-6.7%. CEO Li Xiang expressed confidence in restoring monthly sales to 50,000 units and plans to launch the pure electric SUV i8 in July [1] - Hand Return Group (02621) debuted on the market but fell over 7% on its first day. The company is an internet-based life insurance intermediary with platforms like Xiaoyusan, Kachaba, and Niubao100, raising approximately 134 million HKD from its listing [1] - Yiming Anke-B (01541) surged over 13%, with its stock price doubling within the month. The company announced preliminary efficacy and safety data for its core product IMM2510 in treating non-small cell lung cancer (NSCLC) during I/II phase clinical trials [1] Group 2 - Meizhong Jiahe (02453) increased by over 7%, having developed a proprietary proton therapy language model successfully deployed in a Guangzhou hospital. The company plans to raise approximately 93.94 million HKD through a discounted share placement for equipment procurement, loan repayment, and working capital [2] - Gome Retail (06808) rose over 6%, with reports indicating that after a major shareholder change, the company is on track to transform its business, focusing on sales scale and absolute gross profit by FY2026. The company turned profitable in the second half of the last fiscal year, reporting a net profit of 199 million yuan, and plans to distribute 1.5 billion yuan in dividends for FY2025 [2] - Sany International (00631) saw a rise of over 4%, reporting a 14.6% year-on-year revenue increase to 5.876 billion yuan and a 23.2% rise in net profit to 635 million yuan for Q1. Growth was attributed to global expansion, digitalization, and low-carbon strategies [2] Group 3 - Dekang Agriculture (02419) surged over 8%, with analysts noting that April pig prices remained strong despite the seasonal downturn, and May's supply-demand dynamics are expected to support rising pig prices. The company is recognized for its leading breeding costs, projected to be below 13 yuan per kilogram, with an estimated 30% growth in pig output over the next three years [3] - Fubo Group (03738) increased by over 13%, completing an oversubscribed financing of over 500 million HKD for AI research and financial optimization. The company reported a total revenue increase of approximately 23% year-on-year, with mainland China revenue growing by about 21% and monthly recurring revenue (MRR) increasing by around 30% [3] - Gako Si-B (01167) rose over 8%, with a cumulative increase of over 25% this week. The company received domestic approval for its KRAS G12C inhibitor, used in specific non-small cell lung cancer treatments [3] - Fosun Pharma (02196) increased by over 6%, announcing that its self-developed new drug, Luwo Meitini tablets, has been approved for market release by the National Medical Products Administration [3] Group 4 - The smartphone supply chain stocks collectively fell, with companies like Hillstone Technology dropping over 5% and Sunny Optical, BYD Electronics, and GoerTek all declining over 3%. This decline was attributed to market concerns following the reinstatement of tariffs from the Trump administration [4] - Xiansheng Pharmaceutical (02096) rose over 8%, with five of its drugs selected for the 2025 ASCO annual meeting. The company's innovative drug BD's international expansion has garnered attention, including a deal with AbbVie worth over 1 billion USD [4] - Yika (09923) surged over 10%, following a 27% increase the previous day. The company recently obtained a payment license in Arizona, USA, with a projected nearly 5-fold increase in overseas transaction volume in 2024 [4] - Stone Pharmaceutical Group (01093) rose over 7%, with ongoing negotiations for three potential transactions involving products like EGFR-ADC, with total potential payments reaching approximately 5 billion USD, one of which is expected to be completed in June [4]

Market Overview - The Hang Seng Index is expected to rise to 24,300 points due to the recent US-China trade talks resulting in a reduction of tariffs, with the US lowering tariffs on Chinese imports from 145% to 30% and China reducing tariffs on US imports from 125% to 10% for a period of 90 days [2] - The market anticipates a new round of financial policies from mainland China, including interest rate cuts and structural monetary policy tools, which are expected to bolster investor confidence in the mainland economy [2] Economic Indicators - The US GDP for the first quarter was slightly revised to a contraction of 0.2%, while the core PCE price index was adjusted down to 3.4% [4] - The Federal Reserve is expected to consider interest rate cuts if large-scale tariffs can be avoided, indicating a cautious approach to future monetary policy adjustments [4][9] Company News - Li Auto (2015) reported a 1.1% increase in revenue to 25.93 billion yuan, but adjusted net profit fell by 20% to 1 billion yuan [11] - JD.com (9618) saw a doubling in user scale and order volume in Hong Kong and Macau over the past two months, with transaction value increasing by 200% [11] - Alibaba's Tmall reported a 283% increase in sales for home appliances and digital products during the first phase of the 618 shopping festival compared to last year's Double 11 [11] - Meituan's flash sales for alcoholic beverages saw an 18-fold increase in overall transaction value compared to the same period last year [11] Sector Focus - The pharmaceutical sector is expected to benefit from renewed COVID-19 outbreaks and ongoing cooperation between Chinese and US pharmaceutical companies [7] - The AI sector is experiencing significant growth, with advancements in models like DeepSeek driving demand [7][11]

Individual Company News - Li Auto (02015.HK) reported a total revenue of 25.9 billion yuan for Q1 2025, representing a year-on-year increase of 1.1%. Adjusted net profit was 1 billion yuan, down 20.5% year-on-year [1] - Sihuan Pharmaceutical (01093.HK) is in discussions with potential partners regarding licensing and collaboration in drug development, production, and commercialization [1] - SANY International (00631.HK) achieved a net profit of 636 million yuan in Q1, a year-on-year increase of 30.6%, driven by significant revenue growth in large port machinery, oil and gas equipment, silicon energy products, and overseas mining vehicle sales [1] - Minxin Group (00222.HK) has jointly established a partnership to invest in a national-level specialized and innovative technology enterprise [1] - China Orient Group (00581.HK) reported an operating profit of approximately 199 million yuan for Q1 after deducting financial costs [1] Pharmaceutical Sector News - Jiahe Biotech (06998.HK) received approval from the Chinese National Medical Products Administration for the market launch of the new drug GB491 [2] - Fosun Pharma (02196.HK) had its registration application for the drug Luwomeitini approved by the National Medical Products Administration [2] - Yum China (09987.HK) entered into a share repurchase agreement for a total buyback amount of approximately 510 million USD for the second half of the year [2]

Group 1: Stablecoin Legislation in Hong Kong - The Hong Kong Legislative Council passed the "Stablecoin Ordinance" on May 21, marking Hong Kong as one of the first regions globally to establish a comprehensive regulatory framework for fiat-backed stablecoins [1] - The Hong Kong Monetary Authority (HKMA) will initiate a licensing system to regulate stablecoin issuance and related activities, with compliance applications expected to be accepted by the end of 2025 [1] - Stablecoins are seen as a means to promote the internationalization of the Hong Kong dollar and the Renminbi, challenge the dominance of the US dollar in the digital currency era, and enhance the cross-border payment environment [1] Group 2: Investment Opportunities and Benefits - Issuers of stablecoins can gain commercial benefits such as minting profits, increasing user engagement within their ecosystems, and expanding customer reach, particularly among unbanked populations [1] - Investors can benefit from stablecoins by avoiding cryptocurrency volatility, meeting cross-border payment needs, participating in DeFi investments, and managing liquidity [1] - Licensed institutions are expected to generate revenue through a combination of interest spreads, fees, and ecosystem services [1] Group 3: Company Announcements and Financial Performance - China Eastern Group reported a sales volume of approximately 1.8 million tons of self-produced steel products for the first quarter, with a gross profit of about 100-150 RMB per ton [9] - Shenzhen Expressway reported a revenue of 97.14 million RMB for its outer ring project in April, reflecting a year-on-year decrease of approximately 9.21% [10] - Sany International reported a revenue of 5.876 billion RMB for the first quarter, a year-on-year increase of 14.6%, with a net profit attributable to shareholders of 635 million RMB, up 23.2% [17]

Financial Performance - The unaudited consolidated revenue for the three months ended March 31, 2025, was approximately RMB 5,876,351,000, an increase of about 14.6% compared to approximately RMB 5,129,582,000 for the same period in 2024[3] - The unaudited consolidated gross profit for the same period was approximately RMB 1,428,440,000, reflecting an increase of about 11.8% from approximately RMB 1,277,520,000 in 2024[3] - The unaudited net profit for the period was approximately RMB 635,548,000, which represents a significant increase of about 30.6% compared to approximately RMB 486,735,000 in the previous year[3] - The profit attributable to equity holders of the parent company was approximately RMB 635,243,000, marking an increase of about 23.2% from approximately RMB 515,673,000 in 2024[4] Strategic Initiatives - The company implemented a global, digital, and low-carbon strategy, resulting in significant revenue increases from large port machinery, oil and gas equipment, silicon energy products, and overseas mining vehicle sales[7] - The acquisition of the lithium business completed on July 22, 2024, has provided new revenue sources for the company[7] - The company has fully implemented digital operations, enhancing quality and efficiency while reducing costs, leading to improved gross profit margins for various product lines[7]

Investment Rating - The report maintains a "Strong Buy" rating for the machinery sector [4] Core Insights - Major companies like Huawei and Tencent are actively collaborating with robotics manufacturers, leveraging their capabilities in application scenarios and AI infrastructure to enhance model training and R&D efficiency, which is expected to accelerate the commercialization of humanoid robots [1][11][41] - The China Securities Index Company has launched the Innovation and Entrepreneurship Robotics Index, which includes 34 companies, indicating a potential influx of capital into the robotics sector, supporting continued market momentum [1][11][41] - The report emphasizes a strong outlook for embodied intelligence, including both humanoid and non-humanoid robots, and encourages exploration of investment opportunities in "AI + Robotics" beyond just humanoid robots [1][11][41] Summary by Sections Humanoid Robots - Major tech giants are enhancing robotics manufacturers' capabilities, which is expected to boost the commercialization of humanoid robots [2][11] - The newly launched robotics index includes companies such as Huichuan Technology, Hubei Zhongke, and others, with expectations for increased capital inflow into the sector [2][11] - The report suggests focusing on embodied intelligence and exploring various robotics applications, including exoskeletons and sensors, which do not necessarily depend on humanoid robot proliferation [2][11] Engineering Machinery - Recent rumors about poor domestic sales data for engineering machinery in early May have led to significant stock corrections among leading companies, but the report suggests that this data may not represent the entire month [12][21] - The report anticipates double-digit growth in domestic sales for the year, supported by a low base from the previous year [12][21] - The domestic market is expected to recover, driven by increased investment in infrastructure and construction projects [21][22] Semiconductor Equipment - The report highlights the increasing importance of domestic semiconductor equipment due to export restrictions from the U.S., which is expected to accelerate the domestic production rate [25][26] - The overall outlook for the semiconductor equipment sector remains positive, with anticipated growth in orders for 2025 [26] 3C Equipment - The report notes that domestic manufacturers are well-positioned to benefit from the ongoing adjustments in Apple's production strategy, with expectations for strong demand in 2025 [27] Other Equipment Sectors - The report provides insights into various sectors, including oil service equipment, elevators, rail transit equipment, and mining machinery, with specific recommendations for companies within these sectors [30][31][32][33]

Core Insights - Major companies like Huawei and Tencent are actively collaborating with robotics manufacturers, leveraging their capabilities in application scenarios and AI infrastructure to empower these manufacturers, which is expected to accelerate the commercialization of humanoid robots [1][2] - The China Securities Index Company has launched the Innovation and Entrepreneurship Robotics Index, which includes 34 companies in its initial sample, indicating an anticipated influx of capital into the robotics sector, supporting ongoing market trends [2] - There is a strong belief in the potential of embodied intelligence, encompassing both humanoid and non-humanoid robots, with a recommendation to explore investment opportunities in "AI + robotics" beyond just humanoid forms [1][2] Industry Dynamics - The collaboration between major tech firms and robotics manufacturers is expected to enhance model training, improve R&D efficiency, and expand application scenarios, thereby fostering the growth of the robotics industry [2] - The initial sample of the Innovation and Entrepreneurship Robotics Index includes notable companies such as Huichuan Technology, Hunan Zhongke, and others, suggesting a broadening interest and investment in the robotics sector [2] - The market is projected to see increased capital inflow, particularly into passive management products, which will further support the robotics sector's performance [2] Other Sectors - The machinery sector is recommended to focus on self-controllable technologies (robotics, semiconductor components), overseas expansion, and dividend assets, with specific companies highlighted for investment [3] - Related companies in the robotics field include Aobo Zhongguang, Lingyi Zhi Zao, and others, indicating a diverse range of investment opportunities within the sector [4]

Investment Rating - The industry investment rating is maintained as "Positive" [1] Core Viewpoints - The engineering machinery industry is experiencing a positive cycle driven by both domestic and overseas demand, with significant revenue growth and improved profitability expected in 2024 and Q1 2025 [3][4] - The "Belt and Road" initiative is expected to boost exports, with a notable increase in overseas market share and a recovery in the domestic cycle anticipated [4][5] Revenue Growth - In 2024, the total revenue of the five major engineering machinery manufacturers reached 259.8 billion, a year-on-year increase of 3% [6][11] - In Q1 2025, the total revenue reached 72.6 billion, marking a year-on-year increase of 12% and a quarter-on-quarter increase of 11% [6][11] Profitability Improvement - The net profit attributable to shareholders for the five major manufacturers in 2024 was 17.9 billion, up 19% year-on-year [24] - In Q1 2025, the net profit reached 6.8 billion, reflecting a year-on-year increase of 42% and a quarter-on-quarter increase of 164% [24] Export Growth - In April 2025, export sales reached 9,595 units, a year-on-year increase of 19.3%, with the "Belt and Road" region accounting for 64% of the total export value in Q1 2025, up 15% year-on-year [4][5] Domestic Market Recovery - Domestic sales in April 2025 reached 12,547 units, a year-on-year increase of 16.4%, indicating a recovery in the domestic cycle [4][5] Investment Recommendations - The report recommends focusing on industry leaders such as SANY Heavy Industry, XCMG, Shantui, and others, while also paying attention to companies like Noli [5] Cash Flow and Financial Health - Operating cash flow for the five major manufacturers increased by 75% in 2024 and by 16% in Q1 2025, indicating improved operational quality [59][62] - The asset-liability ratio for 2024 and Q1 2025 was 57%, showing a year-on-year decrease of 1.7 percentage points and 1.1 percentage points, respectively [65]

证券研究报告 工程机械：反转逻辑持续验证， 内外需共振盈利周期上行 ——工程机械行业2024年与2025Q1业绩综述 行业评级：看好（维持） 2025年5月16日 分析师 邱世梁 分析师 王华君 分析师 胡飘 邮箱 qiushiliang@stocke.com.cn 邮箱 wanghuajun@stocke.com.cn 邮箱 hupiao@stocke.com.cn 电话 18516256639 电话 18610723118 电话 13886125652 证书编号 S1230520050001 证书编号 S1230520080005 证书编号 S1230524040006 分析师 邱世梁 分析师 王华君 分析师 何家恺 研究助理 徐琛奇 邮箱 qiushiliang@stocke.com.cn 邮箱 wanghuajun@stocke.com.cn 邮箱 hejiakai@stocke.com.cn 研究助理 蒋逸 证书编号 S1230520050001 证书编号 S1230520080005 证书编号 S1230523080007 工程机械：反转逻辑持续验证中，海外与国内有望共振 1、回顾2024年&20 ...

Investment Rating - The industry investment rating is "Positive" (maintained) [5] Core Viewpoints - In April 2025, the total sales of excavators reached 22,142 units, representing a year-on-year growth of 17.6%, with domestic sales increasing by 16.4% and export sales rising by 19.3% [2][3] - The excavator sales from January to April 2025 totaled 83,514 units, showing a year-on-year increase of 21.4%, with domestic sales up by 31.9% and export sales up by 9.0% [2] - The demand for small excavators is driven by agricultural and municipal needs, while domestic demand for large and super-large excavators is expected to gradually increase due to water conservancy projects [3] - The loader sales in April 2025 reached 11,653 units, a year-on-year increase of 19.2%, with domestic sales growing by 35.4% [3] - The electric loader sales in April 2025 were 2,924 units, marking a significant year-on-year growth of 211%, with a penetration rate of 25% [15][16] - The report anticipates a gradual recovery in the domestic machinery industry, driven by improved domestic demand, increased export market share, and the initiation of a replacement cycle [3][4] Summary by Sections Excavator Sales - April 2025 excavator sales totaled 22,142 units, with domestic sales at 12,547 units and export sales at 9,595 units, reflecting year-on-year growth of 16.4% and 19.3% respectively [2][12] - The sales from January to April 2025 reached 83,514 units, with domestic sales at 49,109 units and export sales at 34,405 units, indicating a year-on-year increase of 31.9% for domestic sales [2] Loader Sales - Loader sales in April 2025 were 11,653 units, with domestic sales at 7,191 units and export sales at 4,462 units, showing a year-on-year increase of 35.4% for domestic sales [3] - The total loader sales from January to April 2025 were 42,220 units, with domestic sales at 23,570 units, reflecting a year-on-year growth of 27.8% [3] Market Trends - The report highlights the ongoing globalization of the Chinese construction machinery industry, with an expected increase in overseas market share [3] - Domestic demand is projected to improve due to government initiatives, including the issuance of long-term special bonds and local government special bonds aimed at infrastructure investment [4] - The report suggests that the domestic replacement cycle for excavators is expected to gradually initiate in 2025, following a historical cycle of 8-10 years [4]